BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
See today's BioWorld
Home
» Peninsula Acquired For $245M; PPI-0903 Destined For Spinout
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Peninsula Acquired For $245M; PPI-0903 Destined For Spinout
April 20, 2005
By
Karen Carey
No Comments
In a $245 million cash-for-stock transaction, Ortho-McNeil Pharmaceutical Inc. signed a definitive agreement to acquire Peninsula Pharmaceuticals Inc. and its lead anti-infective compound, doripenem. (BioWorld Today)
BioWorld